MedPath

Evaluation of Effectiveness and Side Effects of Single and Double surface Intensive Phototherapy

Not Applicable
Conditions
Neonatal jaundice, unspecified
P59.9
non-hemolytic hyperbilirubinemia.
Registration Number
IRCT20191203045595N1
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
150
Inclusion Criteria

Healthy term infant, with non-hemolytic hyperbilirubinemia with total serum bilirubin between 15-20 mg/dl
1-14 days old

Exclusion Criteria

Asphyxia
Pre-term

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Indirect bilirubin level. Timepoint: Before intervention and then every 24 hours until discharge. Method of measurement: Blood test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath